Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Svicher V"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1035
Tytuł:
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals
Autorzy:
Armenia, D.
Gagliardini, R.
Alteri, C.
Svicher, V.
Cento, V.
Borghi, V.
Vergori, A.
Cicalini, S.
Forbici, F.
Fabeni, L.
Bertoli, A.
Brugneti, M.
Gennari, W.
Malagnino, V.
Andreoni, M.
Mussini, C.
Antinori, A.
Perno, C.F.
Santoro, M.M.
Ceccherini-Silberstein, F.
Pokaż więcej
Źródło:
In Journal of Clinical Virology November 2023 168
Czasopismo naukowe
Szczegóły
Tytuł:
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients.
Autorzy:
Gratteri C; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.
Ambrosio FA; Dipartimento di Medicina Sperimentale e Clinica, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.
Lupia A; Dipartimento di Scienze della vita e dell'ambiente, Università degli Studi di Cagliari, Cittadella Universitaria di Monserrato, 09124 Cagliari, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.
Moraca F; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.; Dipartimento di Farmacia, Università degli Studi di Napoli 'Federico II', Via D. Montesano 49, 80131 Napoli, Italy.
Catalanotti B; Dipartimento di Farmacia, Università degli Studi di Napoli 'Federico II', Via D. Montesano 49, 80131 Napoli, Italy.
Costa G; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.
Bellocchi M; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Carioti L; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Salpini R; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Ceccherini-Silberstein F; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Frazia S; Dipartimento di Biologia, Università Tor Vergata di Roma, Via della Ricerca Scientifica, 1, 00133 Roma, Italy.
Malagnino V; Dipartimento di Medicina dei Sistemi, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Sarmati L; Dipartimento di Medicina dei Sistemi, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Svicher V; Dipartimento di Biologia, Università Tor Vergata di Roma, Via della Ricerca Scientifica, 1, 00133 Roma, Italy.
Bryant S; Inte:Ligand GmbH, Mariahilferstrasse 74B/11, 1070 Vienna, Austria.
Artese A; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.
Alcaro S; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Aug 12; Vol. 16 (8). Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing.
Autorzy:
Bellocchi MC; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Scutari R; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Carioti L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Iannetta M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Marchegiani G; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Piermatteo L; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Coppola L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Tedde S; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Duca L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Malagnino V; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Ansaldo L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Braccialarghe N; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
D Anna S; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Santoro MM; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Di Lorenzo A; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Salpini R; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Teti E; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Svicher V; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Andreoni M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Sarmati L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
On Behalf Of The Ptv-Utv-Id-Covid Group
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 09; Vol. 15 (8). Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Spike Glycoprotein, Coronavirus*/genetics
COVID-19*/epidemiology
Humans ; High-Throughput Nucleotide Sequencing ; SARS-CoV-2/genetics ; Retrospective Studies ; Mutation ; Italy/epidemiology ; Glycoproteins
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis.
Autorzy:
Salpini R; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
D'Anna S; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Piermatteo L; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.; Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Svicher V; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.; Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Dec; Vol. 29 (12), pp. 1038-1047. Date of Electronic Publication: 2022 Oct 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hepatitis Delta Virus*/genetics
Liver Neoplasms*
Humans ; Hepatitis B Surface Antigens/genetics ; Hepatitis B virus/genetics ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort.
Autorzy:
Malagnino V; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.; Department of Medicine of Systems, Tor Vergata University of Rome, 00133 Rome, Italy.
Salpini R; Department of Experimental Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.
Teti E; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.
Compagno M; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.; Department of Medicine of Systems, Tor Vergata University of Rome, 00133 Rome, Italy.
Ferrari L; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.
Mulas T; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.
Svicher V; Department of Biology, Tor Vergata University of Rome, 00133 Rome, Italy.
Zordan M; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.
Basso M; Department of Molecular Medicina, University of Padua, 35100 Padova, Italy.
Battagin G; UOC Malattie Infettive, Ospedale di Vicenza, 36100 Vicenza, Italy.
Panese S; UOC Malattie Infettive, Ospedale di Venezia, 30122 Venezia, Italy.
Rossi MC; UOC Malattie Infettive, Ospedale di Treviso, 31100 Treviso, Italy.
Scaggiante R; UOC Malattie Infettive, Ospedale di Belluno, 32100 Belluno, Italy.
Zago D; Department of Molecular Medicina, University of Padua, 35100 Padova, Italy.
Iannetta M; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.; Department of Medicine of Systems, Tor Vergata University of Rome, 00133 Rome, Italy.
Parisi SG; Department of Molecular Medicina, University of Padua, 35100 Padova, Italy.
Andreoni M; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.; Department of Medicine of Systems, Tor Vergata University of Rome, 00133 Rome, Italy.
Sarmati L; Clinical of Infectious Diseases, Tor Vergata Policlinic of Rome, 00133 Rome, Italy.; Department of Medicine of Systems, Tor Vergata University of Rome, 00133 Rome, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jan 10; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Multicenter Study; Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Lamivudine/therapeutic use ; Hepatitis B virus/genetics ; Anti-Retroviral Agents/therapeutic use ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
Autorzy:
Romeo I; Dipartimento di Scienze della Salute, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.; Net4Science Academic Spin-Off, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.
Ambrosio FA; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.
Costa G; Dipartimento di Scienze della Salute, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.; Net4Science Academic Spin-Off, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.
Corona A; Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, 09124 Cagliari, Italy.
Alkhatib M; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Salpini R; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Lemme S; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Vergni D; Istituto per le Applicazioni del Calcolo 'Mauro Picone'-CNR, 00185 Rome, Italy.
Svicher V; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Santoro MM; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Tramontano E; Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, 09124 Cagliari, Italy.
Ceccherini-Silberstein F; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy.
Artese A; Dipartimento di Scienze della Salute, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.; Net4Science Academic Spin-Off, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.
Alcaro S; Dipartimento di Scienze della Salute, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.; Net4Science Academic Spin-Off, Università degli Studi 'Magna Græcia' di Catanzaro, Campus 'S. Venuta', Viale Europa, 88100 Catanzaro, Italy.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Nov 03; Vol. 27 (21). Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19 Drug Treatment*
Humans ; Drug Repositioning ; RNA Helicases/metabolism ; Viral Nonstructural Proteins/metabolism ; DNA Helicases/metabolism ; Antiviral Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis B-Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen-Positive Patient With HIV: Viroimmunological and Histological Characterization.
Autorzy:
Iannetta M; Department of System Medicine, Tor Vergata University, Rome, Italy.
Crea AMA; Department of System Medicine, Tor Vergata University, Rome, Italy.
Di Lorenzo A; Department of System Medicine, Tor Vergata University, Rome, Italy.
Campogiani L; Department of System Medicine, Tor Vergata University, Rome, Italy.
Teti E; Department of System Medicine, Tor Vergata University, Rome, Italy.
Malagnino V; Department of System Medicine, Tor Vergata University, Rome, Italy.
Compagno M; Department of System Medicine, Tor Vergata University, Rome, Italy.
Coppola L; Department of System Medicine, Tor Vergata University, Rome, Italy.
Piermatteo L; Department of Experimental Medicine, Tor Vergata University, Rome, Italy.
Palmieri G; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
Cimino C; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
Salpini R; Department of Experimental Medicine, Tor Vergata University, Rome, Italy.
Zingaropoli MA; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Ciardi MR; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Mastroianni CM; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Parisi SG; Department of Molecular Medicine, University of Padova, Padua, Italy.
Svicher V; Department of Experimental Medicine, Tor Vergata University, Rome, Italy.; Department of Biology, Tor Vergata University, Rome, Italy.
Andreoni M; Department of System Medicine, Tor Vergata University, Rome, Italy.
Sarmati L; Department of System Medicine, Tor Vergata University, Rome, Italy.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Aug 29; Vol. 9 (9), pp. ofac451. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The combined usage of accurate virological and serological HBV markers can help to identify HBsAg-negative/anti-HBc-positive patients at higher risk of HBV-reactivation and to optimize prophylaxis duration in oncohematological setting
Autorzy:
Salpini, R.
Alkhatib, M.
Cerva, C.
Piermatteo, L.
Battisti, A.
Malagnino, V.
Fabeni, L
Cantonetti, M.L.
Arcese, W.
Ceccherini-Silberstein, F.
Perno, C.F.
Andreoni, M.
Sarmati, L.
Svicher, V.
Pokaż więcej
Źródło:
In Digestive and Liver Disease February 2020 52 Supplement 1:e23-e23
Czasopismo naukowe
Szczegóły
Tytuł:
Quantitative HBeAg varies across the different phases of HBV infection, and can predict treatment outcome in the setting of HBV-reactivation driven by iatrogenic immunosuppression
Autorzy:
Piermatteo, L.
Salpini, R.
Alkhatib, M.
Bertoli, A.
Iuvara, A.
De Cristofaro, M.
Cappiello, G.
Cerva, C.
Minichini, C.
Pisaturo, M.
Starace, M.
Coppola, N.
Fontana, C.
Sarmati, L.
Andreoni, M.
Angelico, M.
Grelli, S.
Silberstein, F. Ceccherini
Perno, C.F.
Svicher, V.
Pokaż więcej
Źródło:
In Digestive and Liver Disease February 2020 52 Supplement 1:e21-e22
Czasopismo naukowe
Szczegóły
Tytuł:
A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases
Autorzy:
Salpini, R.
Cerva, C.
Battisti, A.
Piermatteo, L.
Sacco, A.
Malagnino, V.
Arcese, W.
Cantonetti, M.
Ceccherini-Silberstein, F.
Perno, C.F.
Andreoni, M.
Sarmati, L.
Svicher, V.
Pokaż więcej
Źródło:
In Digestive and Liver Disease February 2019 51 Supplement 1:e67-e67
Czasopismo naukowe
Szczegóły
Tytuł:
Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection
Autorzy:
Piermatteo, L.
Battisti, A.
Carioti, L.
Anastasiou, O.
Gill, U.S.
Colagrossi, L.
Bertoli, A.
Aragri, M.
Iuvara, A.
Malagnino, V.
Cerva, C.
Lichtner, M.
Mastroianni, C.M.
De Sanctis, G.M.
Maurizio, P.
Marignani, M.
Pasquazzi, C.
Iapadre, N.
Mari, T.
Parruti, G.
Vecchiet, J.
Sarmati, L.
Andreoni, M.
Mario, A.
Grelli, S.
Kennedy, P.
Verheyen, J.
Silberstein, F. Ceccherini
Perno, C.F.
Salpini, R.
Svicher, V.
Pokaż więcej
Źródło:
In Digestive and Liver Disease February 2019 51 Supplement 1:e60-e60
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 1035

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies